Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab
- PMID: 20189334
- DOI: 10.1016/j.gcb.2010.01.016
Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical

